Unibron Pharmaceutical Private Limited
About Unibron Pharmaceutical Private Limited
Data last updated:
Unibron Pharmaceutical Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC303657. Its GSTIN is 27AACCU1884B1ZG (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kiran Devi Dharmendra Singh and Neha Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 402 Roop Rajat Plaza Chs Ltd 150 Feet Road Near Reena Mehta College, Thane, Maharashtra, India – 401101.
As per the financials filed for FY 2024, the company reported a revenue of ₹56,000, a decline of 96% compared to the previous year. For the same year it recorded a net loss of ₹1.28 Lakh (net margin -229.2%) and EBITDA of -₹1.28 Lakh (EBITDA margin -229.2%). Revenue has declined at a compounded annual rate (CAGR) of 78% over three years.
Company details
Contact details
Unibron Pharmaceutical Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressA – 402 Roop Rajat Plaza Chs Ltd 150 Feet Road Near Reena Mehta College, Thane, Maharashtra, India – 401101
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Unibron Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Unibron Pharmaceutical is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Unibron Pharmaceutical Private Limited, buy the company report.
Financials of Unibron Pharmaceutical Private Limited
FY 2025 filings availableUnibron Pharmaceutical Private Limited reported revenue of ₹56,000 (down 96% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 78% over three years, including a 96% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.28 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -229.2% | ||||
| Net Profit Margin | -229.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unibron Pharmaceutical Private Limited, buy the company report.
Board of directors of Unibron Pharmaceutical Private Limited
Unibron Pharmaceutical has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kiran Devi Dharmendra Singh Also directs: Suplog Supply Chain Solutions Private Limited | Additional Director | 16 Feb 2024 | 2 Years 8 Months | Current |
| Neha Singh Also directs: Zielen Logistics Private Limited | Additional Director | 21 Mar 2024 | 2 Years 7 Months | Current |
Peer comparison
Unibron Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Agapeglobal Reach Foundation | ₹56,291 (FY 2024) | Kolkata, West Bengal, India | ||||
| Shri Dayal Natural Spine Care Private Limited | ₹56,242 (FY 2021) | Dausa, Rajasthan, India | ||||
| Sneh Care Club Private Limited | ₹56,201 (FY 2024) | 314.0% | Bhopal, Madhya Pradesh, India | |||
| Yugen Marketing & Manufacturing Private Limited | ₹56,200 (FY 2025) | -73.0% | Kolkata, West Bengal, India | |||
| International Buddhist Foundation | ₹56,093 (FY 2023) | Indore, Madhya Pradesh, India | ||||
| Unibron Pharmaceutical Private Limitedthis company | ₹56,000 (FY 2024) | -₹1.28 Lakh | -229.2% | -96.0% | Thane, Maharashtra, India | |
| Dhanraksha Dealcomm Private Limited | ₹55,550 (FY 2025) | 4.0% | Kolkata, West Bengal, India | |||
| Sunsyn Healthcare Private Limited | ₹55,500 (FY 2021) | Pune, Maharashtra, India | ||||
| Pradhuman Pharmaceuticals Private Limited | ₹55,050 (FY 2024) | Etah, Uttar Pradesh, India | ||||
| Si Nuclear Diagnostics and Therapy Private Limited | ₹55,003 (FY 2021) | Bathinda, Punjab, India | ||||
| Yusr International Private Limited | ₹55,000 (FY 2025) | -95.0% | Delhi, India |
To see the full peer comparison of Unibron Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Unibron Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unibron Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unibron Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCU1884B1ZG | Maharashtra | Active | 23 Feb 2018 |
To see the full GST registrations and return filing status of Unibron Pharmaceutical Private Limited, buy the company report.
Recent activity
Unibron Pharmaceutical Private Limited has 7 board changes on record since 2021: 2 appointments and 5 cessations. The latest: Kajal Sameer Medda ceased to be Director on 21 Mar 2024.
Frequently asked questions
Unibron Pharmaceutical is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 January 2018 (8+ years old) and is registered under CIN U74999MH2018PTC303657.
Unibron Pharmaceutical has 2 current directors:
- Kiran Devi Dharmendra Singh - Additional Director
- Neha Singh - Additional Director
The latest financial statements of Unibron Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Unibron Pharmaceutical is 27AACCU1884B1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Unibron Pharmaceutical is U74999MH2018PTC303657. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unibron Pharmaceutical was incorporated on 04 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Unibron Pharmaceutical by revenue are Agapeglobal Reach Foundation, Shri Dayal Natural Spine Care Private Limited, Sneh Care Club Private Limited, Yugen Marketing & Manufacturing Private Limited, International Buddhist Foundation and 5 more, all in the same principal business activity (other hospital and medical care activities).
Kajal Sameer Medda ceased to be Director on 21 Mar 2024. Neha Singh was appointed as Additional Director on 21 Mar 2024. Kiran Devi Dharmendra Singh was appointed as Additional Director on 16 Feb 2024. Unibron Pharmaceutical has 7 board changes on record in total.
The registered office of Unibron Pharmaceutical is at A – 402 Roop Rajat Plaza Chs Ltd 150 Feet Road Near Reena Mehta College, Thane, Maharashtra, India – 401101.
Unibron Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Unibron Pharmaceutical can be reached at its registered office: A – 402 Roop Rajat Plaza Chs Ltd 150 Feet Road Near Reena Mehta College, Thane, Maharashtra, India – 401101.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
